Comprehensive analysis of transferrin receptor (TFRC) as a prognostic biomarker for patients with bladder cancer

Asian J Surg. 2024 Feb;47(2):1104-1106. doi: 10.1016/j.asjsur.2023.10.129. Epub 2023 Nov 22.

Authors

Zhiwei Jiang¹, Yetong Wang², Zhouting Tuo³

Affiliations

¹ Department of Urology, Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
² The Fourth Corps of Students of the Basic Medical College, Army Medical University, Chongqing, 400038, China.
³ Department of Urology, Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China. Electronic address: tuozhouting@gmail.com.

PMID: 37996378
DOI: 10.1016/j.asjsur.2023.10.129

No abstract available

Keywords: BLCA; Cancer biomarker; Immune microenvironment; TFRC.

Publication types

Letter

MeSH terms

Humans
Prognosis
Receptors, Transferrin*
Urinary Bladder Neoplasms*

Substances

Receptors, Transferrin